Navigation Links
Study finds prenatal diagnosis and birth location may significantly improve neonatal HLHS survival
Date:10/23/2013

HOUSTON (Oct. 23, 2013) A first-of-its-kind study led by Texas Children's Hospital and Baylor College of Medicine (BCM), published online in the journal, Circulation, found that infants with hypoplastic left heart syndrome (HLHS) born far from a hospital providing neonatal cardiac surgery for HLHS have increased neonatal mortality, with most deaths occurring before surgery. Researchers also concluded that efforts to improve prenatal diagnosis of HLHS and subsequent delivery near a large volume cardiac surgical center may significantly improve neonatal HLHS survival. For more information on the study, visit circ.ahajournals.org.

"Our study is the first to examine the interactions between prenatal diagnosis, birth location and cardiac surgical center volume to determine survival among infants with HLHS," said Dr. Shaine Morris, lead researcher, pediatric cardiologist at Texas Children's Hospital and assistant professor of pediatrics cardiology at BCM. "These findings are essential to providing the most successful outcomes for our patients." HLHS occurs when the fetus's left side of the heart does not develop normally, and is present in approximately 1 in 6,000 live births. HLHS is one of the most complex heart defects to treat because most of the structures on the left side of the heart are too small and underdeveloped or hypoplastic and it is difficult for the heart to provide enough red blood flow for the body's needs. The rate of mortality is quite high in HLHS, and optimal outcomes depend on aggressive cardiology and surgical management. All children with HLHS will have to undergo at least three surgeries within the first three years of life to survive, but many die in the first few months of life.

"Babies can be diagnosed with HLHS in-utero or after they are born," explained Dr. Daniel J. Penny, chief of cardiology at Texas Children's, professor and head of the section of cardiology in the department of pediatrics at BCM and contributing author on the study. "This study sheds light on delivery distance in addition to prenatal and postnatal diagnosis. If an infant is diagnosed after they are born, it is crucial that they are cared for at a center with expertise and high HLHS volumes."

The research, conducted by experts from BCM, the Texas Department of State Health Services, University of Texas Southwestern Medical Center in Dallas and the University of South Florida, used the Texas Department of State Health Services' Texas Birth Defects Registry data from 1999-2007 to retrospectively examine the associations between distance from birth center to a cardiac surgical center, number of newborns cared for with HLHS at each hospital, and neonatal mortality in infants with HLHS.

Of the more than 3.4 million births during the study period, 463 infants with HLHS were assessed. Mothers delivering farther from a cardiac surgical center were less educated and more often lived in a poverty-stricken area. Additionally, 39 percent of newborns studied were prenatally diagnosed with HLHS and delivered significantly closer to a cardiac surgical center. Forty percent of newborns with HLHS died that were born more than 90 minutes from a cardiac surgical center, compared to 21 percent of those born within 10 minutes of a surgical center. The percentage of patients that died after the first surgery for HLHS was two to four times higher in low volume surgical centers than in the highest volume centers. Overall, in the latest years of the study, newborns with a prenatal diagnosis, born less than10 minutes from a cardiac surgical center, and cared for at a large volume cardiac surgical center, had a neonatal mortality of 6 percent. For those born in the same era without a prenatal diagnosis, more than10 miles from a cardiac surgical center, and cared for at a low volume cardiac surgical center, 28-day mortality was 29 percent.

Texas Children's Heart Center is one of only ten cardiac surgical centers that offer the first surgery for HLHS in the state of Texas, and is one of the highest volume congenital heart surgery centers in the country. Additionally, the Heart Center works in close collaboration with Texas Children's Fetal Center at Texas Children's Pavilion for Women to identify and begin treatment of this complex heart issue in-utero. The Fetal Center is one of only a few centers in the world capable of performing complex fetal intervention as it involves a coordinated effort among a large, multidisciplinary team of fetal cardiologists, OBGYNs, interventional cardiologists, congenital heart surgeons, fetal imaging experts, maternal and fetal anesthesiologists and other clinical specialists.

"Previously, parents had limited options when they received an early diagnosis of HLHS during pregnancy," said Dr. Michael Belfort, obstetrician and gynecologist-in-chief at Texas Children's Hospital and chairman of obstetrics and gynecology at BCM. "Now, through the collaborative work of the Fetal and

Heart Centers at Texas Children's Pavilion for Women, families have more options and we are seeing even better outcomes for these babies." For more than 50 yearscirc.ahajournals.org, Texas Children's Heart Center has cared for children with congenital heart defects, like HLHS, and treats more than 17,000 children and performs more than 800 surgeries annually.

"If you're able to deliver at or near a high volume cardiac surgical center, you're likely to have the best outcome for your child," added Morris. "Our multidisciplinary team has the expertise to care for fetuses in-utero all the way into adulthood." Texas Children's Heart Center is committed to consistently providing outcomes that are among the best in the nation. As part of this commitment, Texas Children's has a dedicated Surgical Outcomes Center devoted to patients and families through a commitment to track and improve clinical outcomes, transparency in sharing those outcomes and advocating for care to be provided where the best outcomes can be achieved.


'/>"/>

Contact: Lindsey Fox
lbfox@texaschildrens.org
832-824-2040
Texas Children's Hospital
Source:Eurekalert

Related medicine news :

1. Study finds testosterone therapy may reduce risk of cardiovascular disease
2. New Study Tracks Latest Changes in New York Workers’ Compensation System after 2007 Reforms
3. Los Angeles Parathyroid Surgeon Responds to Study Indicating Advantages of Minimally Invasive Parathyroid Surgery
4. Flu shot halves risk of heart attack or stroke in people with history of heart attack, study finds
5. Flu shot halves risk of heart attack or stroke in people with history of heart attack, study finds
6. Opioids for chronic pain: Study looks at how patients and their doctors talk about risks
7. Study Examines Connections Between Depression and Breast Cancer, Allsup Reports
8. New Autism Study Reveals Effectiveness of Web-Based Intervention Tool for Challenging Behaviors
9. Tufts Medical Center to lead 20-center study on vitamin Ds effect on Type 2 diabetes
10. UCLA gets $7 million to study substance use and HIV among minority men who have sex with men
11. Large prospective study finds long-term obesity is associated with poorer pancreatic cancer survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: